Y-mAbs Therapeutics, Inc.
YMAB
$8.54
$0.0050.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.71% | -30.31% | -38.45% | -23.76% | 36.99% |
| Total Depreciation and Amortization | -45.87% | -37.22% | -27.21% | -26.12% | -25.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.90% | 20.29% | 29.35% | -7.79% | -22.59% |
| Change in Net Operating Assets | -416.85% | 28.94% | 81.51% | 50.05% | 93.29% |
| Cash from Operations | -41.76% | -8.89% | 42.30% | 21.46% | 72.56% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -1.43% | 457.70% | 4,211.00% | -- | 4,603.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.43% | 457.70% | 4,211.00% | -- | 4,603.85% |
| Foreign Exchange rate Adjustments | -150.00% | -105.88% | -100.00% | 106.12% | 107.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.55% | 8.54% | 57.96% | 34.00% | 77.92% |